Difference between revisions of "Profiles"
Jump to navigation
Jump to search
Line 5: | Line 5: | ||
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]] | * [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]] | ||
+ | '''UPICT protocol''' | ||
+ | *[[Media:UPICT Oncologic FDG-PETCTProtocol Dec-2014a.pdf|UPICT Oncology FDG-PET CT Protocol, v2.5 Dec-2014]] | ||
+ | *[[Media:UPICT Oncologic FDG-PETCTProtocol 5-20-14.pdf|UPICT Oncology FDG-PET CT Protocol 05-20-2014]] | ||
===[[QIBA_Profile_Stages#Stage_2:_Consensus|Stage 2]]: Consensus Profiles=== | ===[[QIBA_Profile_Stages#Stage_2:_Consensus|Stage 2]]: Consensus Profiles=== |
Revision as of 22:05, 20 September 2017
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
UPICT protocol
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
The following Profiles are open for Public Comment:
- QIBA fMRI Profile 2017-06-19 Open until September 19, 2017
Please submit all public comments through the following online form: http://tinyurl.com/QIBA-Public-Comment-Form
(Note: each form accommodates 10 comments; you may submit additional forms as necessary)
Public Comment closed for the following Profiles (comment resolution is currently underway):
- QIBA PET Amyloid Profile 2017-06-15 (Closed on September 15, 2017)
- QIBA MRE Profile 2017-08-15 (Closed on September 15, 2017)
- DWI Profile 2017-04-27 (Closed on August 25, 2017)
- QIBA Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening Profile 2016-06-01 (Closed Sept 2016)
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)